Bombesin analogs

C - Chemistry – Metallurgy – 07 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07K 7/02 (2006.01)

Patent

CA 2144264

The invention features linear therapeutic peptides of the following formula: R1 A1-A-A3-A4-A5-A6-A7-A8-A9-R3, R2 in which A1 is a D-.alpha.-aromatic amino acid or a D-.alpha.- tethered amino acid; A is Gln, His, 1-methyl-His, or 3- methyl-His; A3 is the D- or L-isomer selected from Nal, Trp, Phe, and p-X-Phe, where X is F, Cl, Br, NO2, OH or CH3; A4 is Ala, Val, Leu, Ile, Nle, or .alpha.-aminobutyric acid; A5 is Val, Ala, Leu, Ile, Nle, Thr, or .alpha.- aminobutyric acid; A6 is .beta.-Ala; A7 is His, 1-methyl-His, 3-methyl-His, Lys, or .epsilon.-alkyl-Lys; A8 is Leu, Ile, Val, Nle, .alpha.-aminobutyric acid, Trp, Pro, Nal, Chx-Ala, Phe, or p-X-Phe, where X is F, Cl, Br, NO2, OH or CH3; A9 is Met, Met-oxide, Leu, Ile, Nle, .alpha.-aminobutyric acid, or Cys; each R1 and R2, independently, is H, C1-12 alkyl, C7-10 phenylalkyl, or COE1, where E1 is C1-20 alkyl, C3-20 alkenyl, C3-20 alkynyl, phenyl, 3,4-dihydroxyphenylalkyl, naphthyl, or C7-l0 phenylalkyl; provided that when either R1 or R2 is COE1, the other must be H; and R3 is OH, NH2, C1-12 alkoxy, C7-10 phenylalkoxy, C11-20 naphthylalkoxy, C1- 12 alkylamino, C7-10 phenylalkylamino, C11-20 naphthylalkylamino; or a pharmaceutically acceptable salt of such peptides.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Bombesin analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bombesin analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bombesin analogs will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1988276

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.